White House’s Covid coordinator urges people to get vaccinated ahead of holidays

White House’s Covid coordinator urges people to get vaccinated ahead of holidays


White House COVID-19 Response Coordinator Ashish Jha at the White House in Washington, October 25, 2022.

Jonathan Ernst | Reuters

As Covid and flu hospitalizations have climbed in the weeks since Thanksgiving, White House’s Covid-19 coordinator Dr. Ashish Jha said families will be safer at upcoming holiday gatherings if they get their updated vaccines.

This year, hospitals are facing the simultaneous threat of Covid, flu and RSV for the first time. Circulation of flu and RSV was very low during the pandemic due to widespread masking and social distancing implemented in response to Covid, but as most people return to normal life, all three viruses are circulating widely.

As of Dec. 14, the 7-day average of weekly new Covid cases reached 65,067, a 2.9% decrease from the previous week, according to CDC data.

“The good news here is that we can prevent those infections from turning into serious illness if people go out and get that updated bivalent vaccine,” Jha told ABC’s “This Week” Sunday.

Public health officials have said many people are probably more vulnerable to flu and RSV this year because they weren’t infected in the past two years, which means their immunity is lower. Around 23,503 patients were admitted to the hospital with influenza this week, the CDC reported, while RSV hospitalizations appear to have peaked in some states.

Hospitalizations of people with Covid topped more than 5,000 per day on average, according to the CDC.

“The updated vaccine is essential for keeping people out of the hospital,” Jha said. “So we’re making the case that we’re at a point where it’s safe to gather, but you still have things to do.”



Source

Eli Lilly investors shouldn’t sweat rival Novo Nordisk having the first obesity pill on sale
Health

Eli Lilly investors shouldn’t sweat rival Novo Nordisk having the first obesity pill on sale

Jim Cramer says don’t sweat Novo Nordisk’s head start over Club holding Eli Lilly in the obesity pill market. Eli Lilly stock slipped about half a percent this morning, while Novo Nordisk shares surged more than 8% after becoming the first to secure FDA approval for a GLP-1 weight-loss pill. “[Novo] got approval ahead of […]

Read More
FDA approves first GLP-1 pill for obesity from Wegovy maker Novo Nordisk
Health

FDA approves first GLP-1 pill for obesity from Wegovy maker Novo Nordisk

The logo of pharmaceutical company Novo Nordisk is displayed in front of its offices in Bagsvaerd, on the outskirts of Copenhagen, Denmark, Nov. 24, 2025. Tom Little | Reuters The U.S. Food and Drug Administration on Monday approved the first-ever GLP-1 pill for obesity from Wegovy maker Novo Nordisk, a landmark decision that health experts […]

Read More
UnitedHealth Group commits to improvements after independent audit, patient backlash
Health

UnitedHealth Group commits to improvements after independent audit, patient backlash

UnitedHealthcare sign is displayed at its office building in Minnetonka, Minnesota, U.S., Dec. 11, 2025. Tim Evans | Reuters UnitedHealth Group on Friday released the first results from a sprawling independent audit of its business practices and committed to a wide range of steps to track and implement improvements in three specific areas. The health-care […]

Read More